# Benzydamine in Sore Throat Pain Relief (BePaiR Study)

> **NCT04941976** · PHASE4 · COMPLETED · sponsor: **Aziende Chimiche Riunite Angelini Francesco S.p.A** · enrollment: 356 (actual)

## Conditions studied

- Acute Sore Throat

## Interventions

- **DRUG:** 0.3% benzydamine hydrochloride spray oromucosal solution
- **DRUG:** Single 3 mg lozenge of benzydamine hydrochloride (mint flavour)

## Key facts

- **NCT ID:** NCT04941976
- **Lead sponsor:** Aziende Chimiche Riunite Angelini Francesco S.p.A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-13
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 356 (ACTUAL)
- **Last updated:** 2021-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04941976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04941976, "Benzydamine in Sore Throat Pain Relief (BePaiR Study)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04941976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*